A peptide derived from human prothrombin fragment 2 inhibits prothrombinase and angiogenesis

Thrombosis Research

Volumn 106, Issue 1, 2002, Pages 81-87

  Kim, Bum Joon ^a   Koo, So Young ^a   Kim, Soung Soo ^a  

^a Yonsei University   (South Korea)

Author keywords

Angiogenesis; Coagulation; Endothelium; Factor Xa; Peptide fragments; Prothrombin

Indexed keywords

ASPARAGINYLSERYLALANYLVALYLLEUCYLGLUTAMINYLVALYLGLUTAMYLASPARAGINE; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; CALCIUM; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4E7; PEPTIDE DERIVATIVE; PHOSPHOLIPID; PROTHROMBIN; UNCLASSIFIED DRUG; ANGIOGENESIS INHIBITOR; PEPTIDE FRAGMENT; PEPTIDE LIBRARY; PROTHROMBIN FRAGMENT 2; THROMBOPLASTIN;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CELL PROLIFERATION; CELL SURFACE; CELL VACUOLE; CHICK EMBRYO; CONTROLLED STUDY; DRUG EFFECT; EMBRYO; ENDOTHELIUM CELL; ENZYME INHIBITION; KINETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CATTLE; CELL DIVISION; CHEMISTRY; CYTOLOGY; DRUG ANTAGONISM; HUMAN; MOLECULAR GENETICS; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

AMINO ACID SEQUENCE; ANGIOGENESIS INHIBITORS; ANIMALS; CAPILLARIES; CATTLE; CELL DIVISION; CHICK EMBRYO; ENDOTHELIUM, VASCULAR; HUMANS; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PROTHROMBIN; THROMBOPLASTIN;

EID: 0036544676     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(02)00086-5     Document Type: Article

References (40)

1. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes
2. Prothrombin
3. 2+ binding and activation kinetics
4. Interaction of clotting factor V heavy chain with prothrombin and prethrombin 1 and role of activated protein C in regulating this interaction
5. Modulation of human prothrombin activation on phospholipid vesicles and platelets using monoclonal antibodies to prothrombin fragment 2
6. Blood coagulation factor Xa interacts with a linear sequence of the kringle 2 domain of prothrombin
7. Endothelial cells in physiology and in the pathophysiology of vascular disorders
8. Role of endothelium in thrombosis and hemostasis
9. Thrombin-induced endothelial cell dysfunction
10. Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells
11. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors
12. Effects of thrombin/thrombosis in angiogenesis and tumour progression
13. Prothrombin kringle-2 domain has a growth inhibitory activity against basic fibroblast growth factor-stimulated capillary endothelial cells
14. Human prothrombin fragment 1 and 2 inhibit bFGF-induced BCE cell growth
15. Expression, purification, and characterization of prothrombin kringle 2
16. A simple method for the preparation of homogeneous phospholipid vesicles
17. Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates
18. Activation of prothrombin in the presence of human umbilical-vein endothelial cells
19. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
20. Abnormalities of hemostasis in malignancy
21. Cancer and blood coagulation: Molecular aspects
22. Molecular basis for the relationship between thrombosis and cancer
23. Activation of coagulation and angiogenesis in cancer: Immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer
24. The biology and tumour-related properties of monocyte tissue factor
25. Tissue factor-a receptor involved in the control of cellular properties, including angiogenesis
26. Anti-angiogenic activity of the cleaved conformation of the serpin antithrombin
27. The hemostatic system as a regulator of angiogenesis
28. Prothrombin is activated on vascular endothelial cells by factor Xa and calcium
29. Hemostatic properties of normal and perturbed vascular cells
30. Cellular effects of initiation of the extrinsic pathway of blood coagulation
31. Activation of prothrombin by factor Xa bound to the membrane surface of human umbilical vein endothelial cells: Its catalytic efficiency is similar to that of prothrombinase complex on platelets
32. Inhibition of metastases by anticoagulants
33. Isolation and characterization of antistasin. An inhibitor of metastasis and coagulation
34. DX9065a, an Xa inhibitor, inhibits prothrombin-induced A549 lung adenocarcinoma cell proliferation
35. Ancylostoma caninum anticoagulant peptide blocks metastasis in vivo and inhibits factor Xa binding to melanoma cells in vitro
36. Therapeutic potentials of angiostatin in the treatment of cancer
37. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
38. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis
39. A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4
40. Disruption of angiogenesis by PEX, a non-catalytic metalloproteinase fragment with integrin binding activity